Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Qi Biodesign
Qi Biodesign secures $75M for genome editing technology
By
Anthony Vecchione
|
01:32 pm |
December 10, 2024
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.
